This brand name is authorized in Estonia, Spain, Romania, Singapore
The drug CUPRIPEN contains one active pharmaceutical ingredient (API):
|
1
D-penicillamine
UNII GNN1DV99GX - PENICILLAMINE
|
|
Penicillamine is a chelating agent which aids the elimination from the body of certain heavy metal ions, including copper, lead and mercury, by forming stable soluble complexes with them that are readily excreted by the kidney. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M01CC01 | Penicillamine | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01C Specific antirheumatic agents → M01CC Penicillamine and similar agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1688351 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 53172, 54830 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W61063002 |
| Country: SG | Health Sciences Authority | Identifier(s): 08173P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
